HEADER METALLOPROTEASE 23-DEC-93 1SRT OBSLTE 10-JUL-95 1SRT 2SRT TITLE THE NMR STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN OF TITLE 2 HUMAN STROMELYSIN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS METALLOPROTEASE EXPDTA NMR, 15 STRUCTURES AUTHOR P.R.GOOLEY REVDAT 1 26-JAN-95 1SRT 0 JRNL AUTH P.R.GOOLEY,J.F.O'CONNELL,A.I.MARCY,G.C.CUCA, JRNL AUTH 2 S.P.SALOWE,B.L.BUSH,J.D.HERMES,C.K.ESSER, JRNL AUTH 3 W.K.HAGMANN,J.P.SPRINGER,B.A.JOHNSON JRNL TITL THE NMR STRUCTURE OF THE INHIBITED CATALYTIC JRNL TITL 2 DOMAIN OF HUMAN STROMELYSIN-1 JRNL REF NAT.STRUCT.BIOL. V. 1 111 1994 JRNL REFN ASTM NSBIEW US ISSN 1072-8368 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.R.GOOLEY,B.A.JOHNSON,A.I.MARCY,G.C.CUCA, REMARK 1 AUTH 2 S.P.SALOWE,W.K.HAGMANN,C.K.ESSER,J.P.SPRINGER REMARK 1 TITL SECONDARY STRUCTURE AND ZINC LIGATION OF HUMAN REMARK 1 TITL 2 RECOMBINANT SHORT-FORM STROMELYSIN BY REMARK 1 TITL 3 MULTIDIMENSIONAL HETERONUCLEAR NMR REMARK 1 REF BIOCHEMISTRY V. 32 13098 1993 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SRT COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1SRT THE TURNS REPRESENTED IN *TURN* RECORDS BELOW ARE 1SRT REMARK 5 RECOGNIZED BY NOE PATTERNS, AND THE PRESENCE OF A SLOW 1SRT REMARK 5 EXCHANGING NH PROTON AT POSITION I+3. HOWEVER, HYDROGEN REMARK 5 1SRT BONDS HAVE NOT BEEN INCLUDED IN THE CALCULATION OF THE REMARK 5 1SRT MODELS. FOR THE TURN MARKED MET-TURN IT IS NOT CLEAR REMARK 5 IF IT 1SRT IS TYPE I OR II (NH PROTON OF MET 219 AND TYR REMARK 5 220 OVERLAP). 1SRT REMARK 6 REMARK 6 1SRT THE CARBOXYLATE OF THE INHIBITOR RESIDUE 256 (INH) IS REMARK 6 1SRT RESTRAINED AS A MONODENTATE LIGAND OF THE ZINC. REMARK 6 STRUCTURES 1SRT HAVE BEEN CALCULATED WITH AND WITHOUT THIS REMARK 6 RESTRAINT 1SRT AND ASSUMING MONO OR BI-DENTATE LIGATION. NO REMARK 6 SIGNIFICANT 1SRT DIFFERENCES HAVE BEEN OBSERVED. THE REMARK 6 BINDING SITES OF THE 1SRT INHIBITOR SIDE CHAINS ARE REMARK 6 IDENTIFIED BY THE NOMENCLATURE 1SRT OF SCHECTER, I. & REMARK 6 BERGER, A. (P1', P2', P3' OF THE 1SRT INHIBITOR; S1', S2', REMARK 6 S3' ARE THE CORRESPONDING BINDING 1SRT SITES OF THE REMARK 6 PROTEIN). 1SRT P1': PHENYLETHYL (HOMOPHENYLALANINE) 1SRT REMARK 6 P2': ARGININE 1SRT P3': PHENYLAMIDE (ANILIDE) 1SRT REMARK 7 REMARK 7 1SRT INH IS N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYL ETHYL) REMARK 7 1SRT GLYCYL-L-ARGININE-N-PHENYLAMIDE. 1SRT REMARK 8 REMARK 8 1SRT CROSS REFERENCE TO SEQUENCE DATABASE 1SRT SWISS-PROT REMARK 8 ENTRY NAME PDB ENTRY CHAIN NAME 1SRT COG3_HUMAN 1SRT REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : NULL REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP 158 -77.83 70.95 REMARK 500 1 ASP 189 -93.41 -170.96 REMARK 500 2 PHE 86 158.60 73.14 REMARK 500 2 ASP 158 -71.36 80.19 REMARK 500 2 ASP 189 -111.82 -161.87 REMARK 500 3 ASN 162 -79.91 72.34 REMARK 500 3 VAL 163 127.52 103.82 REMARK 500 4 ASP 189 -118.10 -171.24 REMARK 500 5 VAL 163 121.95 95.28 REMARK 500 6 ASP 158 123.61 64.15 REMARK 500 6 ALA 217 -165.10 13.74 REMARK 500 6 SER 252 148.92 63.95 REMARK 500 7 ASN 162 -73.39 79.52 REMARK 500 7 VAL 163 122.20 96.03 REMARK 500 7 ASN 175 132.24 72.92 REMARK 500 8 GLU 139 144.01 63.61 REMARK 500 8 ASP 153 168.32 70.32 REMARK 500 8 ASP 189 -106.97 -159.70 REMARK 500 8 HIS 224 -114.21 -155.81 REMARK 500 9 VAL 163 130.54 85.94 REMARK 500 10 ILE 89 121.97 66.21 REMARK 500 11 GLU 139 155.66 61.14 REMARK 500 11 ASP 153 162.43 67.15 REMARK 500 11 ASP 251 169.31 57.70 REMARK 500 12 PHE 86 140.58 69.46 REMARK 500 12 ASP 189 -116.34 -154.27 REMARK 500 12 SER 252 155.37 61.84 REMARK 500 13 PHE 86 149.53 85.86 REMARK 500 13 ASP 189 -98.35 -174.14 REMARK 500 14 SER 252 129.69 65.04 REMARK 500 15 VAL 163 142.25 60.43 SEQRES 1 173 PHE ARG THR PHE PRO GLY ILE PRO LYS TRP ARG LYS THR SEQRES 2 173 HIS LEU THR TYR ARG ILE VAL ASN TYR THR PRO ASP LEU SEQRES 3 173 PRO LYS ASP ALA VAL ASP SER ALA VAL GLU LYS ALA LEU SEQRES 4 173 LYS VAL TRP GLU GLU VAL THR PRO LEU THR PHE SER ARG SEQRES 5 173 LEU TYR GLU GLY GLU ALA ASP ILE MET ILE SER PHE ALA SEQRES 6 173 VAL ARG GLU HIS GLY ASP PHE TYR PRO PHE ASP GLY PRO SEQRES 7 173 GLY ASN VAL LEU ALA HIS ALA TYR ALA PRO GLY PRO GLY SEQRES 8 173 ILE ASN GLY ASP ALA HIS PHE ASP ASP ASP GLU GLN TRP SEQRES 9 173 THR LYS ASP THR THR GLY THR ASN LEU PHE LEU VAL ALA SEQRES 10 173 ALA HIS GLU ILE GLY HIS SER LEU GLY LEU PHE HIS SER SEQRES 11 173 ALA ASN THR GLU ALA LEU MET TYR PRO LEU TYR HIS SER SEQRES 12 173 LEU THR ASP LEU THR ARG PHE ARG LEU SER GLN ASP ASP SEQRES 13 173 ILE ASN GLY ILE GLN SER LEU TYR GLY PRO PRO PRO ASP SEQRES 14 173 SER PRO GLU THR FTNOTE 1 THE FIRST SEVEN RESIDUES (83 - 90) ARE POORLY ASSIGNED AND FTNOTE 1 THEREFORE ARE ALSO ILL-DEFINED. FTNOTE 2 THE LAST SEVEN RESIDUES OF THE PROTEIN (248 - 255) ARE FTNOTE 2 ASSIGNED BUT SHOW FEW NOES AND ARE THEREFORE ILL-DEFINED. FTNOTE 3 THE FORTH LIGAND OF ZINC 258 HAS NOT BEEN ASSIGNED. THE FTNOTE 3 LIKELY LIGAND IN THESE STRUCTURES IS ASP 153. HET ZN 257 1 HET ZN 258 1 HET INH 256 70 HETNAM ZN ZINC ION HETNAM INH N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)GLYCYL-L- HETNAM 2 INH ARGININE-N-PHENYLAMIDE FORMUL 2 ZN 2(ZN 2+) FORMUL 4 INH C25 H35 N6 O4 1+ HELIX 1 A ASP 111 VAL 127 1 17 HELIX 2 B LEU 195 SER 206 1 12 HELIX 3 C ASP 238 GLY 247 1NOE DATA POOR 10 SHEET 1 S1 5 LEU 130 LEU 135 0 SHEET 2 S1 5 THR 95 ILE 101 1 N TYR 99 O SER 133 SHEET 3 S1 5 ILE 142 ALA 147 1 N ILE 144 O ARG 100 SHEET 4 S1 5 GLY 176 ASP 181 1 N ALA 178 O MET 143 SHEET 5 S1 5 LEU 164 TYR 168 -1 N HIS 166 O HIS 179 TURN 1 T1 ASN 162 ALA 165 TYPE II TURN 2 T2 ILE 174 ASP 177 TYPE II TURN 3 T3 ASP 181 GLU 184 TYPE I TURN 4 T4 ALA 217 TYR 220 MET-TURN SITE 1 S1' 4 LEU 197 VAL 198 PRO 221 TYR 223 SITE 1 S2' 1 VAL 163 SITE 1 S3' 2 LEU 164 LEU 222 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1